Epilepsy News and Research

Latest Epilepsy News and Research

New study looks at academic outcomes of children following resective epilepsy surgery

A new study by a University of Toronto Mississauga researcher has taken the first-ever look at the academic outcomes of children with epilepsy who have had brain surgery, and found that they have a higher chance of struggling in class following their surgery.

3 Jun 2015

Upsher-Smith announces FDA approval of sNDA for Qudexy XR extended-release capsules

Upsher-Smith Laboratories, Inc. announced that it has received U.S. Food and Drug Administration approval of a supplemental new drug application (sNDA) for Qudexy XR (topiramate) extended-release capsules for use as initial monotherapy in patients two years of age and older who are experiencing partial-onset seizures (POS) or primary generalized tonic-clonic seizures.

2 Jun 2015

New insights on strategies to treat infants with seizures

New recommendations offer insights on strategies for treating infants with seizures. In an Epilepsia report, child neurologists who are members of the International League Against Epilepsy note that intervening at the time of a febrile seizure does not alter the risk for subsequent epilepsy, and there is no evidence to support the use of antiepileptic drugs for simple febrile seizures.

2 Jun 2015

Lenvatinib-everolimus combination extends PFS in patients with mRCC versus everolimus alone

Eisai Inc. announced today results from an investigational Phase 2 trial which showed that lenvatinib, when used in combination with everolimus, significantly extended progression-free survival (PFS) in patients with metastatic renal cell carcinoma (mRCC) versus everolimus alone.

1 Jun 2015

Precision medicine helps improve patient health and reduces risk of side effects, says Penn Medical School dean

The rapidly emerging field of precision medicine is a "disruptive innovation" that offers the possibility of remarkably fine-tuned remedies to improve patient health while minimizing the risk of harmful side effects, says J. Larry Jameson, MD, PhD, dean of the Perelman School of Medicine and executive vice president of the University of Pennsylvania for the Health System, in this week's issue of the New England Journal of Medicine.

1 Jun 2015

Eisai Phase 3 trial of eribulin meets primary endpoint in patients with advanced soft tissue sarcoma

Eisai Inc. announced today the results of its Phase 3 trial (Study 309), which showed that eribulin met the study's primary endpoint evaluating overall survival in patients who had advanced leiomyosarcoma (LMS) or adipocytic sarcoma (ADI), two types of advanced soft tissue sarcoma.

30 May 2015

CHOP Global Health Center performs first rigorous study of CP outcomes in Africa

Cerebral palsy (CP) is the most common cause of childhood disability in the world, affecting between 1 and 2 infants per thousand. But the neurological condition tends to be understudied, especially in developing countries.

29 May 2015

DigiPath, Euphoria partner to set highest medical marijuana patient safety and education standards

DigiPath Labs of Las Vegas, a subsidiary of DigiPath, Inc., has entered into a one-year agreement with Euphoria Wellness to conduct comprehensive safety and potency tests on the products Euphoria will sell in its Las Vegas medical marijuana dispensary.

28 May 2015

People with MS have much greater risk of dying younger compared to people without MS

New research suggests people with multiple sclerosis (MS) may have double the risk of dying early compared to people without MS, with those younger than 59 at a three times higher risk. The study is published in the May 27, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

28 May 2015

Chancellor Angela Merkel calls for new plan to tackle Ebola outbreak at 68th World Health Assembly

Angela Merkel, Chancellor of the Federal Republic of Germany addressed delegates on the first morning of the Sixty-eighth World Health Assembly. "The WHO is the only international organization that has universal political legitimacy on global health issues,” she said.

20 May 2015

Griffith students providing healthcare in Malawi

Malawi was the recent destination for a group of Griffith Health students who found that they could learn more from the disadvantaged local people than they had ever imagined.

19 May 2015

Discovery has clear implications in the quest for new epilepsy treatments

The mission of neural stem cells located in the hippocampus, one of the main regions of the brain, is to generate new neurons during the adult life of mammals, including human beings, of course, and their function is to participate in certain types of learning and responses to anxiety and stress.

18 May 2015

New epilepsy drug holds promise as Alzheimer's treatment

University of British Columbia researchers say a new epilepsy drug holds promise as a treatment for Alzheimer's disease.

7 May 2015

UT Southwestern testing Vivistim System device in stroke patients

UT Southwestern Medical Center will be one of three national sites to pioneer U.S. testing for an implant device that stimulates the vagus nerve in stroke patients to see whether it can help restore lost arm function.

7 May 2015

UT Southwestern's new operating suite integrates surgical and endovascular techniques in one space

UT Southwestern Medical Center has established a Hybrid Cerebrovascular Operating Suite at Zale Lipshy University Hospital that will combine surgical innovations with advanced imaging capabilities for surgical cases related to stroke and brain aneurysms.

7 May 2015

New MGH-developed technology may extend benefits of MRI in patients with implanted devices

New technology developed at the Martinos Center for Biomedical Imaging at Massachusetts General Hospital may extend the benefits of magnetic resonance imaging (MRI) to many patients whose access to MRI is currently limited.

6 May 2015

Ground-breaking study characterizes early-stage Alzheimer's abnormalities in the intact brain

Alzheimer's disease (AD) is a neurodegenerative condition that strikes at the heart of what makes us human: the ability to think, to feel, to remember and to communicate with those around us. The tragedy is compounded by the fact that there is currently no cure, no treatment, and no diagnostic method capable of identifying Alzheimer's at its early stages.

6 May 2015

Tuberous Sclerosis Alliance to observe fourth annual TSC Global Awareness Day

On May 15, the Tuberous Sclerosis Alliance (TS Alliance) will join tuberous sclerosis complex (TSC) organizations around the world to observe the fourth annual TSC Global Awareness Day.

5 May 2015

WHO and UNHCR jointly issue new guide to better identify, manage mental health needs

Worldwide close to 80 million people are currently impacted by humanitarian emergencies arising from natural disasters and armed conflicts, such as those in the Central African Republic, South Sudan, Syrian Arab Republic, Yemen, and more recently, Nepal. WHO estimates 5% to 10% of these people suffer from a mental health condition such as depression as a result of the emergency.

5 May 2015

Electroclinical triggers for repeat MRI in intractable epilepsy identified

Researchers have outlined the electroclinical features typically associated with bottom-of-sulcus dysplasia, the surgical removal of which often cures epilepsy in affected patients.

30 Apr 2015

Epilepsy News and Research

Latest Epilepsy News and Research

New study looks at academic outcomes of children following resective epilepsy surgery

Upsher-Smith announces FDA approval of sNDA for Qudexy XR extended-release capsules

New insights on strategies to treat infants with seizures

Lenvatinib-everolimus combination extends PFS in patients with mRCC versus everolimus alone

Precision medicine helps improve patient health and reduces risk of side effects, says Penn Medical School dean

Eisai Phase 3 trial of eribulin meets primary endpoint in patients with advanced soft tissue sarcoma

CHOP Global Health Center performs first rigorous study of CP outcomes in Africa

DigiPath, Euphoria partner to set highest medical marijuana patient safety and education standards

People with MS have much greater risk of dying younger compared to people without MS

Chancellor Angela Merkel calls for new plan to tackle Ebola outbreak at 68th World Health Assembly

Griffith students providing healthcare in Malawi

Discovery has clear implications in the quest for new epilepsy treatments

New epilepsy drug holds promise as Alzheimer's treatment

UT Southwestern testing Vivistim System device in stroke patients

UT Southwestern's new operating suite integrates surgical and endovascular techniques in one space

New MGH-developed technology may extend benefits of MRI in patients with implanted devices

Ground-breaking study characterizes early-stage Alzheimer's abnormalities in the intact brain

Tuberous Sclerosis Alliance to observe fourth annual TSC Global Awareness Day

WHO and UNHCR jointly issue new guide to better identify, manage mental health needs

Electroclinical triggers for repeat MRI in intractable epilepsy identified

Everything you need to know about epilepsy eBook

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Epilepsy News and Research

Latest Epilepsy News and Research

Everything you need to know about epilepsy eBook

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Newsletters you may be interested in